A mechanistic insight of phytoestrogens used for Rheumatoid arthritis: An evidence-based review
Autor: | Kriti Gupta, Debolina Chakraborty, Sagarika Biswas |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
0301 basic medicine
medicine.drug_class medicine.medical_treatment Anti-Inflammatory Agents Phytoestrogens RM1-950 Pharmacology medicine.disease_cause Arthritis Rheumatoid 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine In vivo Anti-inflammation medicine Animals Humans Rheumatoid arthritis Evidence-Based Medicine business.industry Interleukin General Medicine medicine.disease Treatment Outcome 030104 developmental biology chemistry Estrogen Antirheumatic Agents 030220 oncology & carcinogenesis Phytoestrogen Joints Tumor necrosis factor alpha Hormone therapy Therapeutics. Pharmacology Inflammation Mediators business Oxidative stress Signal Transduction Phytotherapy |
Zdroj: | Biomedicine & Pharmacotherapy, Vol 133, Iss, Pp 111039-(2021) |
ISSN: | 0753-3322 |
Popis: | Assessment of the potential therapeutic benefits offered by naturally occurring phytoestrogens necessitate inspection of their potency and sites of action in impeding the chronic, systemic, autoimmune, joint destructing disorder Rheumatoid arthritis (RA). Possessing structural and functional similarity with human estrogen, phytoestrogen promisingly replaces the use of hormone therapy in eradicating RA symptoms with their anti-inflammatory, anti-oxidative, anti-proliferative, anti-angiogenesis, immunomodulatory, joint protection properties abolishing the harmful side effects of synthetic drugs. Scientific evidences revealed that use of phytoestrogens from different chemical categories including flavonoids, alkaloids, stilbenoids derived from different plant species manifest beneficial effects on RA through various cellular mechanisms including suppression of pro-inflammatory cytokines in particular tumor necrosis factor (TNF-α), interleukin(IL-6) and nuclear factor kappa B (NF-κB) and destructive metalloproteinases, inhibition of oxidative stress, suppressing inflammatory signalling pathways, attenuating osteoclastogenesis ameliorating cartilage degradation and bone erosion. This review summarizes the evidences of different phytoestrogen treatment and their pharmacological mechanisms in both in vitro and in vivo studies along with discussing clinical evaluations in RA patients showing phytoestrogen as a promising agent for RA therapy. Further investigations and more clinical trials are mandatory to clarify the utility of these plant derived compounds in RA prevention and in managing oestrogen deficient diseases in patients. |
Databáze: | OpenAIRE |
Externí odkaz: |